JOURNAL OF CARDIAC FAILURE, cilt.18, ss.379-384, 2012 (SCI İndekslerine Giren Dergi)
Background: Bosentan improves symptoms in patients with Eisenmenger syndrome (ES). This study evaluated the effect of long-term bosentan therapy on cardiac function and its relation to symptomatic benefits in ES patients.